Wuhan Qirui Technology Development Co., Ltd. Donates RMB 100 Million to Huazhong University of Science and Technology

March 1 3 On [date], a donation ceremony was held at Huazhong University of Science and Technology to mark Wuhan Qirui Technology Development Co., Ltd.’s contribution to the University’s Education Development Foundation. Attending the signing ceremony were Yu Zheng, President of Huazhong University of Science and Technology; Zhang Yonghui, Vice President and Secretary of the Party Committee of Tongji Medical College; Academician Martin; Academician Wu Tangchun, Dean of Tongji Medical College; and Wang Chaodong, Chairman of Qirui Technology, along with other senior executives of the group.

▲ Dai Zejian, Secretary-General of the Education Development Foundation, and Hu Yuan, Deputy General Manager of Qirui Technology, signed a donation agreement.

▲ Yang Guoping, Deputy General Manager of Qirui Technology, presented a donation check to Huang Rui, Secretary of the Party Committee of the School of Pharmacy.

▲ Yu Zheng, President of Huazhong University of Science and Technology, presented alumnus Wang Chaodong with a commemorative plaque honoring his donation.

At the donation ceremony, Chairman Wang Chaodong reflected on his academic journey at the university, particularly the Tongji School of Medicine’s longstanding tradition of emphasizing both basic and clinical medicine, as well as its rigorous scholarly environment, which laid a solid foundation for his career in the pharmaceutical industry—especially for the company’s current focus on innovative drug R&D. He expressed his hope that establishing an Early Clinical Research Center at the Tongji School of Medicine would help advance the school’s medical and pharmaceutical disciplines under the new paradigm of medical–engineering integration, thereby enabling the company to more effectively bridge the gap between the non-clinical phase and the early clinical phase of new-drug development. “Death Valley,” and leverage AI to generate more breakthroughs, address more health challenges, and make greater contributions to the advancement of global medicine and drug discovery.

In Guided by the mission of “providing high-quality, specialized products and services for human health,” Qirui Technology is committed to becoming a leading innovator in the life and health sector. Over the years, the company has deeply cultivated therapeutic areas including gastrointestinal disorders, liver diseases, autoimmune diseases, respiratory conditions, cardiovascular diseases, and nephrology, successfully mastering several key technologies in innovative drug development. It has achieved breakthrough progress in the development of innovative therapies for respiratory and autoimmune diseases, establishing itself as a world-class, cutting-edge biopharmaceutical enterprise with strong international competitiveness in these niche markets. 。